98 related articles for article (PubMed ID: 32815140)
41. Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides activate monocytes/macrophages.
Radolf JD; Arndt LL; Akins DR; Curetty LL; Levi ME; Shen Y; Davis LS; Norgard MV
J Immunol; 1995 Mar; 154(6):2866-77. PubMed ID: 7876555
[TBL] [Abstract][Full Text] [Related]
42. Recognition of lipopeptides by Toll-like receptors.
Takeda K; Takeuchi O; Akira S
J Endotoxin Res; 2002; 8(6):459-63. PubMed ID: 12697090
[TBL] [Abstract][Full Text] [Related]
43. Gingipain-dependent augmentation by Porphyromonas gingivalis of phagocytosis of Tannerella forsythia.
Jung YJ; Jun HK; Choi BK
Mol Oral Microbiol; 2016 Dec; 31(6):457-471. PubMed ID: 26434368
[TBL] [Abstract][Full Text] [Related]
44. Identification, cloning, expression, and purification of Francisella lpp3: an immunogenic lipoprotein.
Parra MC; Shaffer SA; Hajjar AM; Gallis BM; Hager A; Goodlett DR; Guina T; Miller S; Collins CM
Microbiol Res; 2010 Sep; 165(7):531-45. PubMed ID: 20006480
[TBL] [Abstract][Full Text] [Related]
45. Two lipoproteins extracted from Escherichia coli K-12 LCD25 lipopolysaccharide are the major components responsible for Toll-like receptor 2-mediated signaling.
Lee HK; Lee J; Tobias PS
J Immunol; 2002 Apr; 168(8):4012-7. PubMed ID: 11937558
[TBL] [Abstract][Full Text] [Related]
46. Signaling pathways induced by lipoproteins derived from Mycoplasma salivarium and a synthetic lipopeptide (FSL-1) in normal human gingival fibroblasts.
Nakamura J; Shibata K; Hasebe A; Into T; Watanabe T; Ohata N
Microbiol Immunol; 2002; 46(3):151-8. PubMed ID: 12008923
[TBL] [Abstract][Full Text] [Related]
47. Inflammatory lipoproteins purified from a toxigenic and arthritogenic strain of Mycoplasma arthritidis are dependent on Toll-like receptor 2 and CD14.
Hasebe A; Mu HH; Washburn LR; Chan FV; Pennock ND; Taylor ML; Cole BC
Infect Immun; 2007 Apr; 75(4):1820-6. PubMed ID: 17283106
[TBL] [Abstract][Full Text] [Related]
48. Preparation and in vitro evaluation of novel lipopeptide transfection agents for efficient gene delivery.
Tarwadi ; Jazayeri JA; Prankerd RJ; Pouton CW
Bioconjug Chem; 2008 Apr; 19(4):940-50. PubMed ID: 18333604
[TBL] [Abstract][Full Text] [Related]
49. Interaction of the lymphoid cell line BCL1 with lipopeptide analogues of bacterial lipoprotein: electron energy loss spectroscopy (EELS) as a novel method to detect the distribution of the activator within the cells.
Wolf B; Uhl B; Hauschildt S; Metzger J; Jung G; Bessler WG
Immunobiology; 1989 Nov; 180(1):93-100. PubMed ID: 2625355
[TBL] [Abstract][Full Text] [Related]
50. Triacylated lipoproteins derived from Mycoplasma pneumoniae activate nuclear factor-kappaB through toll-like receptors 1 and 2.
Shimizu T; Kida Y; Kuwano K
Immunology; 2007 Aug; 121(4):473-83. PubMed ID: 17433078
[TBL] [Abstract][Full Text] [Related]
51. Evidence for a carbohydrate-binding module (CBM) of
Frey AM; Satur MJ; Phansopa C; Parker JL; Bradshaw D; Pratten J; Stafford GP
Biochem J; 2018 Mar; 475(6):1159-1176. PubMed ID: 29483296
[TBL] [Abstract][Full Text] [Related]
52. The Vlp system of Mycoplasma hyorhinis: combinatorial expression of distinct size variant lipoproteins generating high-frequency surface antigenic variation.
Rosengarten R; Wise KS
J Bacteriol; 1991 Aug; 173(15):4782-93. PubMed ID: 1856172
[TBL] [Abstract][Full Text] [Related]
53. Purification of antifungal lipopeptides by reversed-phase high-performance liquid chromatography.
Razafindralambo H; Paquot M; Hbid C; Jacques P; Destain J; Thonart P
J Chromatogr; 1993 Jun; 639(1):81-5. PubMed ID: 8331146
[TBL] [Abstract][Full Text] [Related]
54. Synthetic lipopeptide immunomodulators derived from bacterial lipoprotein: tools for the standardization of in vitro assays.
Bessler WG
Dev Biol Stand; 1992; 77():49-56. PubMed ID: 1426672
[TBL] [Abstract][Full Text] [Related]
55. Localization of an immunodominant 64 kDa lipoprotein (LP 64) in the membrane of Mycoplasma gallisepticum and its role in cytadherence.
Forsyth MH; Tourtellotte ME; Geary SJ
Mol Microbiol; 1992 Aug; 6(15):2099-106. PubMed ID: 1406251
[TBL] [Abstract][Full Text] [Related]
56. Potent inhibition of macrophage responses to IFN-gamma by live virulent Mycobacterium tuberculosis is independent of mature mycobacterial lipoproteins but dependent on TLR2.
Banaiee N; Kincaid EZ; Buchwald U; Jacobs WR; Ernst JD
J Immunol; 2006 Mar; 176(5):3019-27. PubMed ID: 16493060
[TBL] [Abstract][Full Text] [Related]
57. Synthesis and characterization of a dipalmitoylated lipopeptide derived from paralogous lipoproteins of Mycoplasma pneumoniae.
Into T; Dohkan J; Inomata M; Nakashima M; Shibata K; Matsushita K
Infect Immun; 2007 May; 75(5):2253-9. PubMed ID: 17325056
[TBL] [Abstract][Full Text] [Related]
58. Activation of mitogen-activated protein kinase pathways by Mycoplasma fermentans membrane lipoproteins in murine macrophages: involvement in cytokine synthesis.
Rawadi G; Ramez V; Lemercier B; Roman-Roman S
J Immunol; 1998 Feb; 160(3):1330-9. PubMed ID: 9570551
[TBL] [Abstract][Full Text] [Related]
59. Lipopeptides of the N-terminus of Escherichia coli lipoprotein: synthesis, mitogenicity and properties in monolayer experiments.
Prass W; Ringsdorf H; Bessler W; Wiesmüller KH; Jung G
Biochim Biophys Acta; 1987 Jun; 900(1):116-28. PubMed ID: 3297144
[TBL] [Abstract][Full Text] [Related]
60. Identification and characterization of a chymotrypsin-like serine protease from periodontal pathogen, Tannerella forsythia.
Hockensmith K; Dillard K; Sanders B; Harville BA
Microb Pathog; 2016 Nov; 100():37-42. PubMed ID: 27594668
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
